JYJia Yin

Jia Yin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jia Yin has a total of 144 co-authors. Here are the top co-authors by number of shared publications:

  • Juan Liu

    8 shared publications
  • Le Cui

    Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

    8 shared publications
  • Kai Guan

    Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    7 shared publications
  • Hong Li

    Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, People’s Republic of China

    6 shared publications
  • Junda Li

    Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

    5 shared publications
  • Kai Guan

    Department of Allergy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, People’s Republic of China

    5 shared publications

Latest Publications

  • Open Access

    Relative contributions of environmental pollen exposure and host susceptibility to Artemisia-related sensitisation and allergy in a high-exposure region of Northern China: a population-based cross-sectional study

    by Le Cui, Lun Li, Junda Li, Shuang Liu, Xin Li, Ruoyu Ji, Wendong Hao, Bin Wu, Huanhuan Wang, Yanhong Wang, et al.

    Objective: Artemisia pollen is a major airborne allergen in northern China; however, the relative contributions of environmental pollen exposure and host susceptibility to allergic disease remain unclear in high-exposure regions. Methods: A population-based cross-sectional study was conducted in Yulin City, China, involving 12,345 participants recruited through multistage stratified cluster sampling. Serum Artemisia -specific IgE was measured in 3,130 participants. Disease status was classified into healthy, sensitized, allergic rhinitis, and acute asthma exacerbation groups. Regional pollen exposure was categorized into low, medium, and high levels based on monitoring data. Inverse probability weighting was applied to reduce selection bias. Multivariable logistic regression models were used to assess associations. Results: The IPW-adjusted prevalence of Artemisia sensitization, allergic rhinitis, and acute asthma exacerbations was 13.0%, 10.7%, and 1.9%, respectively. Regional pollen concentration was not significantly associated with sensitization or disease outcomes in adjusted models (all P > 0.05). In contrast, host-related factors, including family history of allergy and Artemisia -specific IgE levels, showed consistent associations across disease stages. Family history of allergy was strongly associated with sensitization (OR = 4.57, 95% CI: 3.01–6.95). Increasing Artemisia -specific IgE levels were associated with higher odds of progression from sensitization to clinical disease and from rhinitis to acute asthma exacerbation. Conclusion: In this high-exposure population, host susceptibility factors demonstrated stronger and more consistent statistical associations with Artemisia -related allergic disease than regional pollen concentration. These findings suggest that host heterogeneity may contribute importantly to disease variability in high-exposure environments; however, causal inference is limited by the cross-sectional design and exposure measurement constraints.


  • Data-Driven symptom clustering identifies four potential phenotypes of self-reported postorgasmic illness syndrome: findings from a large Chinese online survey

    by Lun Li, Jia Yin

    Postorgasmic illness syndrome (POIS) is a rare and heterogeneous condition characterized by local and/or systemic symptoms following ejaculation. However, whether distinct clinical phenotypes exist remains unclear. We aimed to identify symptom-dominant phenotypes among men with self-reported POIS-like symptoms and to explore variations in the history of allergic diseases across the resulting phenotypes. An online cross-sectional survey was conducted via social media from December 2020 to August 2021 using the WenJuanXing web application. A two-step cluster analysis was performed using 26 variables from POIS-related symptoms and history of allergic diseases. A total of 2,443 men completed the survey, including 770 with self-reported POIS-like symptoms. A four-cluster solution (BIC = 39,404.98; ratio of distance measures = 1.42; ratio of BIC changes = 0.34) was selected. Cluster 1 represented the generalized type (81 patients, 10.5%) characterized by longer spontaneous recovery time with widespread disorders, including mental, flu-like, head, muscle symptoms and mostly reported atopic status. Cluster 2 represented the neuropsychiatric type (235 patients, 30.5%) comprised subjects with fewer atopic symptoms and predominantly mental symptoms, particularly concentration and memory difficulties. Cluster 3, or the nasal type (185 patients, 24.0%) mainly showed atopic and nasal symptoms, while cluster 4, or the oligosymptomatic type (269 patients, 34.9%) had fewer symptoms, faster symptom onset after ejaculation, shorter spontaneous recovery time, and fewer atopic symptoms. All 26 variables included in the clustering model differed significantly across clusters (P <0.001). Recruitment via social media may have introduced selection bias, potentially limiting the generalizability of these findings. The four identified phenotypes reflect the clinical variability of POIS and offer a preliminary framework for future phenotype-based investigations.

  • Open Access

    Validity of an Alternaria alternata Skin Prick Test Extract for Diagnosing Sensitization

    by Xin Li, Jianqing Gu, Ruiqi Wang, Lianglu Wang, Hong Li, Jinlyu Sun, Yuxiang Zhi, Kai Guan, Liping Wen, Zixi Wang, et al.

    Background: Alternaria alternata is a major fungal allergen, yet standardized skin prick test (SPT) extracts are lacking in China, hindering the use of this simple, first-line diagnostic tool. Objective: This study aimed to clinically evaluate a novel, domestically developed A. alternata extract for SPT and establish a diagnostic cutoff in a Chinese population. Patients and Methods: In this prospective, single-center study, 910 patients with allergic diseases were consecutively enrolled. All underwent SPT with the in-house A. alternata extract (Alt a 1: 25.7– 34.8 µg/mL). Serum-specific IgE (sIgE) (ImmunoCAP™) served as the reference standard. Diagnostic accuracy was analyzed using receiver operating characteristic (ROC) curves. Safety was assessed by monitoring adverse events. Results: The per-protocol set included 610 subjects. The area under the ROC curve was 0.868 (95% CI: 0.839– 0.897). The optimal diagnostic cutoff was a mean wheal diameter of 3.25 mm, yielding a sensitivity of 81.10% (95% CI: 76.76%– 85.24%) and specificity of 79.32% (95% CI: 74.46%– 84.18%). To achieve 95% specificity, the cutoff increased to 4.25 mm. No adverse events were reported among all 910 participants. Conclusion: The novel A. alternata SPT extract demonstrates high diagnostic accuracy for detecting Alternaria alternata sensitization and an excellent safety profile. The established cutoff of 3.25 mm provides a population-optimized threshold for identifying sensitized individuals in China. This study addresses a critical gap in allergen standardization and supports the use of SPT as a reliable first-line tool for assessing fungal sensitization in clinical practice. Trial Registration: ChiCTR ChiCTR1800014899. Registered 13 February 2018 (retrospectively registered).

  • Open Access

    Baseline Immune Signatures in Serum Extracellular Vesicles Distinguish Food-Induced from Wheat-Dependent Exercise-Induced Anaphylaxis

    by Junda Li, Tengze Shang, Kai Guan, Jia Yin

    Food-induced anaphylaxis (FIA) is a life-threatening allergic reaction, while wheat-dependent exercise-induced anaphylaxis (WDEIA) is triggered by wheat ingestion plus cofactors. To elucidate their differences, we profiled serum extracellular vesicle (EV) proteomes from 240 participants, including WDEIA, FIA, oral allergy syndrome (OAS), and healthy controls. All blood samples were obtained at least one month after the most recent acute allergic reaction, using TMT-based LC-MS/MS with ELISA validation. A total of 583 EV proteins were confidently identified, revealing distinct immune features. Compared with controls, EV-derived C1-inhibitor (C1-INH) significantly decreased in both WDEIA and FIA, showing diagnostic potential for systemic anaphylaxis. Seventy-six proteins differed between WDEIA and FIA, with reduced apolipoprotein E (APOE) in FIA and elevated eosinophil cationic protein (ECP) in WDEIA, both exhibiting good discriminatory power. These findings indicate that serum EV proteomics can reveal unique immune signatures and identify C1-INH, APOE, and ECP as potential biomarkers distinguishing food-related anaphylaxis subtypes.

  • Open Access

    Assessment of Bronchodilator Responsiveness and Spirometric Patterns in Patients with Rhinitis and Suspected Asthma

    by Zhouxian Pan, Xinyu Liu, Xin Li, Kai Guan, Jia Yin

    Bronchodilation testing (BDT) is routinely used to assess reversibility of airflow limitation. For patients with rhinitis who report asthma-related symptoms but often show preserved spirometry, the clinical patterns associated with bronchodilator responsiveness (BDR) are less clearly described. Understanding these patterns may help clinicians interpret lung function in real-world practice. We retrospectively analyzed 555 consecutive patients who underwent spirometry and BDT at a single tertiary allergy center. Data on clinical symptoms, allergic status, type-2 inflammatory markers, baseline spirometry results, and BDT outcomes were collected. Associations between symptoms, spirometric indices, and BDR were evaluated. Exploratory analyses examined the relationship between FEV1 improvements below the conventional ≥12% criterion and asthma-related symptoms. Among all participants, 71.9% had allergic rhinitis, and 88.6% reported asthma-related symptoms. BDR was observed across a wide range of baseline spirometry values; 47.2% of BDT-positive patients had FEV1 ≥80% predicted. Small airway indices, especially FEF50 % predicted, were strongly associated with BDR. Wheezing and chest tightness demonstrated clearer physiological correlations than coughing alone did. FEV1 improvements slightly below the conventional ≥12% bronchodilator threshold were also associated with asthma-related symptoms, although these findings were exploratory and not intended as diagnostic criteria. In patients with rhinitis and suspected asthma, airflow variability may be present even when FEV1 appears preserved. Small-airway parameters and symptom profiles offer a useful context for interpreting BDT results. Modest FEV1 changes may be clinically relevant and warrant further prospective study. These findings may help clinicians judge when bronchodilation testing is informative during the routine evaluation of suspected airway disease.

  • Open Access

    A nationwide cross-sectional survey of major allergic diseases in China during 2010–2015 involving 120,000 participants

    by Le Cui, Junxiong Zhou, Zheming Wang, Hua Peng, Xiuzhen Sun, Wei Xiao, JingHong Zhang, Hua Zhang, Rongfei Zhu, Wangsheng Yang, et al.

    Although the prevalence of allergic diseases has been rising in China since the late twentieth century, comprehensive nationwide epidemiological data covering all age groups and multiple allergic conditions remain scarce. To investigate the epidemiological patterns of eight major allergic diseases in China, including their national and regional prevalence, demographic distribution, and comorbidity profiles, the National Epidemiology Study of Asthma and Allergies in China (NESAAC) was a nationwide cross-sectional survey conducted from September 2010 to December 2015. A multistage stratified cluster sampling method was employed across seven geographical regions, covering 882 communities and 587 villages in 16 cities. Data were collected via face-to-face interviews using standardized questionnaires. Prevalence was calculated for three categories: lifetime symptoms, current symptoms (past 12 months), and physician-diagnosed history. Among the 121,023 participants analyzed, the current symptom prevalence of each specific disease was: allergic rhinitis (4.2%), asthma (0.9%), eczema (0.7%), drug allergy (0.6%), food allergy (0.4%), urticaria (0.4%), contact dermatitis (0.3%), and anaphylactic shock (0.02%). Geographic variations were notable, with the highest prevalence consistently observed in North, East, and South China. Urban residents had significantly higher prevalence than rural residents across all conditions except anaphylactic shock. Age distribution revealed eczema and food allergy predominance in children under 6 years, whereas asthma and drug allergy prevalence increased with age. Most conditions were more prevalent among females than males. Allergic rhinitis was not only the most common condition but also demonstrated the strongest comorbidity, particularly with asthma. This first nationwide, all-age survey underscores marked epidemiological variations in allergic diseases across China.


  • Open Access

    Clinical Evaluation of an Alternaria alternata Extract Used for Skin Prick Test in Diagnosing

    by Xin Li, Jian-Qing Gu, Ruiqi Wang, Lianglu Wang, Hong Li, Jin-Lu Sun, Yu Xiang Zhi, Kai Guan, Liping Wen, Zixi Wang, et al.

    \articletype Original Articles Background: Alternaria alternata is a major fungal allergen, yet standardized skin prick test (SPT) extracts are lacking in China, hindering the use of this simple, first-line diagnostic tool. This study aimed to clinically evaluate a novel, domestically developed A. alternata extract for SPT and establish a diagnostic cutoff in a Chinese population. Methods: In this prospective, single-center study, 910 patients with allergic diseases were consecutively enrolled. All underwent SPT with the in-house A. alternata extract (Alt a 1: 25.7–34.8 µg/mL). Serum-specific IgE (sIgE) (ImmunoCAP™) served as the reference standard. Diagnostic accuracy was analyzed using receiver operating characteristic (ROC) curves. Safety was assessed by monitoring adverse events. Results: The per-protocol set included 610 subjects. The area under the ROC curve was 0.868 (95% CI: 0.839–0.897). The optimal diagnostic cutoff was a mean wheal diameter of 3.25 mm, yielding a sensitivity of 79.32% (95% CI: 74.46%–84.18%) and specificity of 86.11% (95% CI: 82.35%–89.87%). To achieve 95% specificity, the cutoff increased to 4.25 mm. No adverse events were reported among all 910 participants. Conclusion: The novel A. alternata SPT extract demonstrates high diagnostic accuracy and an excellent safety profile. The established cutoff of 3.25 mm provides a population-optimized threshold for clinical diagnosis in China. This study addresses a critical gap in allergen standardization and supports the adoption of SPT as a reliable, first-line diagnostic tool for fungal allergy in clinical practice.

  • Open Access

    Wheat-Dependent Exercise-Induced Anaphylaxis Patients on a Wheat-Free Diet Exhibit a Gut Microbiota Composition More Similar to Healthy Individuals

    by Zhirong Du, Lun Li, Juan Liu, Haoning Wang, Junda Li, Yingyang Xu, Le Cui, Jia Yin

    There are limited studies on the intestinal microbiome in patients with wheat-dependent exercise-induced anaphylaxis (WDEIA), and changes in the gut microbiome in WDEIA patients after wheat-free diet have not been studied. This is a cross-sectional analysis. Fecal samples and clinical data were collected from 26 non-wheat-free patients with WDEIA, 11 wheat-free patients with WDEIA, and 24 healthy controls (HCs). The gut microbiota was evaluated through metagenomic sequencing. The sequencing revealed differences in the gut microbiome between patients with WDEIA on a non-wheat-free diet and HCs; more specifically, the non-wheat-free group exhibited a downregulation of two families (Rikenellaceae and Odoribacteraceae), three genera (Alistipes, Odoribacter, and Catenibacterium), and four species (Bacteroides_stercoris, Alistipes_putredinis, Bacteroides_intestinalis, and Bacteroides_cellulosilyticus). A wheat-free diet is associated with intestinal flora more similar to the structure of healthy individuals. The species Bacteroides_stercoris was negatively correlated with T-IgE, and the genus Catenibacterium was negatively correlated with T-IgE, as well as wheat, gluten, or gliadin-specific IgE. The genus Catenibacterium was positively correlated with the healthy control-enriched “Apoptosis (ko04210)” pathway and negatively correlated with the non-wheat-free WDEIA group-enriched “Thyroid hormone signaling pathway (ko04919)” pathway. Patients with WDEIA exhibit a specific gut microbiota signature and function, which demonstrated the potential association between the gut microbiome and WDEIA development. WDEIA patients on a wheat-free diet exhibit a gut microbiome composition more similar to healthy individuals.


  • Open Access

    A retrospective analysis of the clinical efficacy in patients treated with Alternaria alternata and Dermatophagoides farinae immunotherapy

    by Juan Liu, Jia Yin

    Background: The clinical efficacy of allergen-specific immunotherapy (AIT) for Alternaria alternata (A. alt) and Dermatophagoides farinae (Der f) extracts remains largely unknown in China. We sought to retrospectively evaluate the efficacy caused by AIT agents manufactured in China of patients who are sensitized to A. alt and Der f.Methods: Patients aged 5–27 years with asthma and perennial allergic rhinitis (AR), and AIT with A. alt and Der f were recruited, and then classified into two groups: A. alt-AIT (n = 31) and A. alt + Der f-AIT group (n = 39). All data were gathered retrospectively, including biological parameters, pulmonary function, and symptom and medication scores.Results: 70 patients who underwent A. alt and Der f AIT were enrolled. A significant improvement was observed in the values of FEV1% (P < 0.0001) and MEF 25 (P = 0.023) of lung function. Both the rhinitis symptoms and combined symptoms and medication scores for asthma decreased after AIT (by 45.3% and 80.3%, respectively, P < 0.0001 for each). Nearly 67% improvement rate (P < 0.0001) occurred in rhinoconjunctivitis quality of life, and a great increase existed in Asthma Control Test (ACT) score (P < 0.0001) after at least 1 year AIT, although there were no significant changes between these two groups. Besides, no significance was displayed in specific IgE to different allergens.Conclusion: AIT with A. alt and Der f extracts had clinical efficacy for many patients in China, with a reduction of symptom and medication scores, and great improvement in spirometry function.